Carmat (ALCAR) - Cash Flow Conversion Efficiency

Latest as of December 2024: 0.344x

Based on the latest financial reports, Carmat (ALCAR) has a cash flow conversion efficiency ratio of 0.344x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-17.58 Million ≈ $-20.56 Million USD) by net assets (€-51.13 Million ≈ $-59.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Carmat for the company's overall valuation and market capitalisation.

Carmat - Cash Flow Conversion Efficiency Trend (2010–2024)

This chart illustrates how Carmat's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Carmat Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Carmat ranked by their cash flow conversion efficiency. See Carmat cash flow to debt ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Creative Medical Technology Holdings Inc NASDAQ:CELZ	-0.170x
Arcadia Minerals Ltd AU:AM7	-0.015x
Highfield Resources Ltd AU:HFR	-0.047x
Surya Biru Murni Acetylene Tbk PT JK:SBMA	0.022x
James Halstead PLC LSE:JHD	0.106x
Avon Protection PLC LSE:AVON	0.014x
Evolution Energy Minerals Ltd AU:EV1	-0.274x
Solis Minerals Ltd V:SLMN	-0.043x

Annual Cash Flow Conversion Efficiency for Carmat (2010–2024)

The table below shows the annual cash flow conversion efficiency of Carmat from 2010 to 2024. View Carmat (ALCAR) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-51.13 Million ≈ $-59.78 Million	€-43.31 Million ≈ $-50.64 Million	0.847x	-30.68%
2023-12-31	€-43.76 Million ≈ $-51.16 Million	€-53.48 Million ≈ $-62.52 Million	1.222x	+104.05%
2022-12-31	€1.80 Million ≈ $2.11 Million	€-54.38 Million ≈ $-63.57 Million	-30.175x	-788.21%
2021-12-31	€-13.72 Million ≈ $-16.04 Million	€-60.17 Million ≈ $-70.34 Million	4.385x	+179.66%
2020-12-31	€7.82 Million ≈ $9.14 Million	€-43.03 Million ≈ $-50.31 Million	-5.504x	-232.89%
2019-12-31	€24.34 Million ≈ $28.46 Million	€-40.24 Million ≈ $-47.05 Million	-1.653x	+11.04%
2018-12-31	€20.54 Million ≈ $24.01 Million	€-38.17 Million ≈ $-44.63 Million	-1.859x	-337.96%
2017-12-31	€57.21 Million ≈ $66.88 Million	€-24.28 Million ≈ $-28.38 Million	-0.424x	+42.37%
2016-12-31	€28.89 Million ≈ $33.77 Million	€-21.27 Million ≈ $-24.87 Million	-0.736x	+93.99%
2015-12-31	€1.40 Million ≈ $1.64 Million	€-17.19 Million ≈ $-20.09 Million	-12.248x	-407.32%
2014-12-31	€7.76 Million ≈ $9.08 Million	€-18.75 Million ≈ $-21.92 Million	-2.414x	-81.08%
2013-12-31	€7.23 Million ≈ $8.45 Million	€-9.64 Million ≈ $-11.27 Million	-1.333x	+26.17%
2012-12-31	€9.94 Million ≈ $11.62 Million	€-17.95 Million ≈ $-20.99 Million	-1.806x	-400.34%
2011-12-31	€26.89 Million ≈ $31.44 Million	€-9.71 Million ≈ $-11.35 Million	-0.361x	+19.55%
2010-12-31	€15.49 Million ≈ $18.11 Million	€-6.95 Million ≈ $-8.13 Million	-0.449x	--

About Carmat

PA:ALCAR France Medical Devices

Market Cap

$7.44 Million

€6.36 Million EUR

Market Cap Rank

#28200 Global

#500 in France

Share Price

€0.10

Change (1 day)

+0.00%

52-Week Range

€0.10 - €0.10

All Time High

€53.45